| 12421228 |
Naphthyridine derivatives as PRC2 inhibitors |
Aaron Craig Burns, Matthew Arnold Marx |
2025-09-23 |
| 12371435 |
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors |
Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora +1 more |
2025-07-29 |
| 12304915 |
SOS1 inhibitors |
Matthew Arnold Marx, Christopher Ronald Smith, John David Lawson, Aaron Craig Burns, Xiaolun Wang +2 more |
2025-05-20 |
| 12280055 |
Combination therapies |
Jacob Haling, Shilpi Khare |
2025-04-22 |
| 12252493 |
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer |
Matthew Arnold Marx, Aaron Craig Burns |
2025-03-18 |
| 12098139 |
Chemokine receptor modulators and uses thereof |
Jeffrey J. Jackson, Akinori Okano, Maureen Kay Reilly, Omar Robles-Resendiz, Jacob Bradley Schwarz +4 more |
2024-09-24 |
| 11964989 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John David Lawson, Matthew Arnold Marx +21 more |
2024-04-23 |
| 11702418 |
SOS1 inhibitors |
Matthew Arnold Marx, Christopher Ronald Smith, John David Lawson, Aaron Craig Burns, Xiaolun Wang +2 more |
2023-07-18 |
| 11492351 |
MTA-cooperative PRMT5 inhibitors |
Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, Aaron Craig Burns, John David Lawson +3 more |
2022-11-08 |
| 11485738 |
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors |
Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora +1 more |
2022-11-01 |
| 11479551 |
MTA-cooperative PRMT5 inhibitors |
Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, Aaron Craig Burns, John David Lawson +3 more |
2022-10-25 |
| 11453683 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John David Lawson, Matthew Arnold Marx +21 more |
2022-09-27 |
| 11384064 |
Chemokine receptor modulators and uses thereof |
Jeffrey J. Jackson, Akinori Okano, Maureen Kay Reilly, Omar Robles-Resendiz, Jacob Bradley Schwarz +4 more |
2022-07-12 |
| 11220509 |
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors |
Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora +1 more |
2022-01-11 |
| 11192879 |
Chemokine receptor modulators and uses thereof |
Jeffrey J. Jackson, Akinori Okano, Maureen Kay Reilly, Omar Robles-Resendiz, Jacob Bradley Schwarz +4 more |
2021-12-07 |
| 11091495 |
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors |
Matthew Arnold Marx, Matthew Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora +1 more |
2021-08-17 |
| 10722514 |
Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof |
Berenger Biannic, Xinping Han, Dennis X. Hu, Paul Robert Leger, Jack Maung +5 more |
2020-07-28 |
| 10683280 |
Chemokine receptor modulators and uses thereof |
Jeffrey J. Jackson, Akinori Okano, Maureen Kay Reilly, Omar Robles-Resendiz, Jacob Bradley Schwarz +4 more |
2020-06-16 |
| 10647715 |
KRas G12C inhibitors |
Matthew Arnold Marx, Thomas P. Bobinski, Aaron Craig Burns, John Gaudino, Julia Haas +5 more |
2020-05-12 |
| 10604526 |
Chemokine receptor modulators and uses thereof |
Hilary Plake Beck, Berenger Biannic, Minna Bui, Dennis X. Hu, Jay P. Powers +8 more |
2020-03-31 |
| 10246462 |
Chemokine receptor modulators and uses thereof |
Hilary Plake Beck, Berenger Biannic, Minna Bui, Dennis X. Hu, Jeffrey J. Jackson +8 more |
2019-04-02 |
| 10179787 |
Chemokine receptor modulators and uses thereof |
Hilary Plake Beck, Berenger Biannic, Minna Bui, Dennis X. Hu, Jeffrey J. Jackson +8 more |
2019-01-15 |